# Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)

> **NCT07654062** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shandong Provincial Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Prediabetes
- Impaired Fasting Glucose
- Impaired Glucose Tolerance (Prediabetes)

## Interventions

- **DRUG:** Mazdutide
- **DRUG:** Placebo
- **BEHAVIORAL:** Standardized Lifestyle Intervention

## Key facts

- **NCT ID:** NCT07654062
- **Lead sponsor:** Shandong Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-06
- **Final completion:** 2029-07
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07654062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07654062, "Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07654062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*